MATINAS BIOPHARMA HOLDINGS, INC. Operating Cash Flow
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Operating Cash Flow of -$3.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.84M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.60M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.51M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.47M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$7.01M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$15.88M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$15.28M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$19.16M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.44M 10-Q · filed 2026-08-13 | -$4.95M derived: sum of 3 quarters · filed 2026-08-13 | -$6.42M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$1.60M 10-Q · filed 2026-05-08 | -$3.11M derived: sum of 2 quarters · filed 2026-05-08 | -$4.58M derived: sum of 3 quarters · filed 2026-05-08 | -$6.61M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.98M derived: sum of 2 quarters · filed 2026-03-31 | -$5.00M derived: sum of 3 quarters · filed 2026-08-13 | -$7.01M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.50M derived: sum of 2 quarters · filed 2026-08-13 | -$5.50M 10-Q · filed 2025-11-10 | -$9.01M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.03M 10-Q · filed 2026-08-13 | -$7.54M derived: sum of 3 quarters · filed 2026-08-13 | -$11.04M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$2.01M 10-Q · filed 2026-05-08 | -$5.52M derived: sum of 2 quarters · filed 2026-05-08 | -$9.02M derived: sum of 3 quarters · filed 2026-05-08 | -$12.12M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$7.01M derived: sum of 2 quarters · filed 2026-03-31 | -$10.12M derived: sum of 3 quarters · filed 2026-03-31 | -$15.88M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$6.61M derived: sum of 2 quarters · filed 2025-11-10 | -$12.38M 10-Q · filed 2025-11-10 | -$16.95M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$8.88M 10-Q · filed 2025-08-14 | -$13.45M derived: sum of 3 quarters · filed 2025-08-14 | -$17.87M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$5.77M 10-Q · filed 2025-05-15 | -$10.35M derived: sum of 2 quarters · filed 2025-05-15 | -$14.77M derived: sum of 3 quarters · filed 2025-05-15 | -$16.96M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$9.00M derived: sum of 2 quarters · filed 2025-04-15 | -$11.19M derived: sum of 3 quarters · filed 2025-04-15 | -$15.28M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | -$4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$6.61M derived: sum of 2 quarters · filed 2024-11-13 | -$10.70M 10-Q · filed 2024-11-13 | -$15.00M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$6.28M 10-Q · filed 2024-08-14 | -$10.58M derived: sum of 3 quarters · filed 2024-08-14 | -$15.55M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$4.09M 10-Q · filed 2024-05-09 | -$8.39M derived: sum of 2 quarters · filed 2024-05-09 | -$13.36M derived: sum of 3 quarters · filed 2024-05-09 | -$18.49M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$9.27M derived: sum of 2 quarters · filed 2024-03-27 | -$14.40M derived: sum of 3 quarters · filed 2024-03-27 | -$19.16M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$10.10M derived: sum of 2 quarters · filed 2023-11-08 | -$14.86M 10-Q · filed 2023-11-08 | -$14.86M 10-Q · filed 2022-11-02 | -$18.81M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$9.89M 10-Q · filed 2023-08-09 | -$9.89M 10-Q · filed 2022-08-11 | -$13.84M derived: sum of 3 quarters · filed 2023-08-09 | -$19.59M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$4.76M 10-Q · filed 2023-05-10 | -$4.76M 10-Q · filed 2022-05-12 | -$8.71M derived: sum of 2 quarters · filed 2023-05-10 | -$14.46M derived: sum of 3 quarters · filed 2023-05-10 | -$15.33M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$9.71M derived: sum of 2 quarters · filed 2023-03-15 | -$10.57M derived: sum of 3 quarters · filed 2023-03-15 | -$15.22M 10-K · filed 2023-03-15 | -$15.22M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$5.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$6.61M derived: sum of 2 quarters · filed 2022-11-02 | -$11.27M 10-Q · filed 2022-11-02 | -$15.57M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | -$864.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$5.52M 10-Q · filed 2022-08-11 | -$9.82M derived: sum of 3 quarters · filed 2022-08-11 | -$15.05M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$4.65M 10-Q · filed 2022-05-12 | -$8.96M derived: sum of 2 quarters · filed 2022-05-12 | -$14.19M derived: sum of 3 quarters · filed 2022-05-12 | -$17.35M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$4.31M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | -$9.53M derived: sum of 2 quarters · filed 2022-03-11 | -$12.70M derived: sum of 3 quarters · filed 2022-03-11 | -$17.37M 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | -$5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$8.40M derived: sum of 2 quarters · filed 2021-11-08 | -$13.06M 10-Q · filed 2021-11-08 | -$17.96M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | -$3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$7.83M 10-Q · filed 2021-08-10 | -$12.73M derived: sum of 3 quarters · filed 2021-08-10 | -$16.81M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$4.66M 10-Q · filed 2021-05-10 | -$9.56M derived: sum of 2 quarters · filed 2021-05-10 | -$13.64M derived: sum of 3 quarters · filed 2021-05-10 | -$15.73M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$8.97M derived: sum of 2 quarters · filed 2021-03-29 | -$11.07M derived: sum of 3 quarters · filed 2021-03-29 | -$14.09M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$6.17M derived: sum of 2 quarters · filed 2020-11-06 | -$9.19M 10-Q · filed 2020-11-06 | -$11.81M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$5.12M 10-Q · filed 2020-08-10 | -$7.74M derived: sum of 3 quarters · filed 2020-08-10 | -$10.38M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$3.02M 10-Q · filed 2020-05-11 | -$5.64M derived: sum of 2 quarters · filed 2020-05-11 | -$8.28M derived: sum of 3 quarters · filed 2020-05-11 | -$10.54M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$5.26M derived: sum of 2 quarters · filed 2020-03-09 | -$7.52M derived: sum of 3 quarters · filed 2020-03-09 | -$10.32M 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | -$2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$4.90M derived: sum of 2 quarters · filed 2019-11-13 | -$7.70M 10-Q · filed 2019-11-13 | -$9.62M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$5.06M 10-Q · filed 2019-08-13 | -$6.98M derived: sum of 3 quarters · filed 2019-08-13 | -$9.76M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$2.81M 10-Q · filed 2019-05-13 | -$4.72M derived: sum of 2 quarters · filed 2019-05-13 | -$7.51M derived: sum of 3 quarters · filed 2019-05-13 | -$11.23M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$4.70M derived: sum of 2 quarters · filed 2019-04-01 | -$8.43M derived: sum of 3 quarters · filed 2019-04-01 | -$11.46M 10-K · filed 2019-04-01 | -$11.46M 10-K · filed 2018-03-16 | |||
| 2017-09-30 | -$2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$6.51M derived: sum of 2 quarters · filed 2018-11-09 | -$9.54M 10-Q · filed 2018-11-09 | -$11.66M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$6.76M 10-Q · filed 2018-08-09 | -$8.88M derived: sum of 3 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | -$3.03M 10-Q · filed 2018-05-09 | -$5.15M derived: sum of 2 quarters · filed 2018-05-09 | ||||||
| 2016-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$6.12M 10-K · filed 2018-03-16 | ||||||
| 2016-09-30 | -$4.00M 10-Q · filed 2017-11-14 | |||||||
| 2015-12-31 | -$7.81M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |